GRECRIN is aiming to advance clinical research in Greece by fostering collaboration and promoting best practices
GRECRIN
GRECRIN - Greek Clinical Research Infrastructure
GRECRIN aspires to provide Greek researchers with the necessary tools to conduct high-quality clinical research and create a point of reference for clinical research excellence in Greece.GRECRIN is headquartered in Thessaloniki at the Institute of Applied Biosciences at the Centre for Research & Technology Hellas, delegated by the General Secretariat for Research and Innovation (GSRI) of the Greek Ministry of Development. GRECRIN connects Research Centers, Universities, researchers, industries and enterprises, hospitals, and patients’ associations through a nationally distributed infrastructure. GRECRIN builds upon the classical clinical research approaches but also emphasizes on the digitalization trend of healthcare.
GRECRIN as a central node
Design, organization and coordination of clinical trials
Consolidation, analysis and interpretation of heterogeneous biomedical data and development of relevant applications, including solutions driven by Artificial Intelligence (AI)
Identification/validation of new predictive biomarkers and new therapeutic targets
Diagnosis and stratification services for acute and chronic diseases, communicable and non-communicable
Drug bioequivalence studies, clinical pharmacology and drug safety research
E-health for citizens / patients and health professionals, including “intelligent” applications along the lines of the AI paradigm.
Provision of specialized services to the Ministry of Health and its supervised bodies and organizations
Development and maintenance of software solutions that can facilitate reproducible clinical studies.
Aims
- to create a point of reference for clinical research excellence in Greece and beyond, driven by the needs of the society
- to constitute the basis for the upscaling of clinical research in Greece and Southeast Europe at large
- to establish new R&I communities with competitive advantages involving exchange of ideas, tools and technologies
- to serve crosscutting fields, going from innovative clinical research paradigms and novel patient-centric clinical study design approaches to exploiting “intelligent” technical paradigms for supporting data management
- to interlink with academia, the industry and policy makers, emphasizing on networking and discussion
- to invest in the training of a new generation of clinical research professionals
- to facilitate closer interactions, cross-disciplinary fertilizations and a wider sharing of information, knowledge and technologies across various fields and between the academia and the industry